The first pan-coronavirus ("universal") vaccine Phase 1 clinical trial results are encouraging for eliciting broad sarbecovirus, SARS-CoV-2 variant immune response www.thelancet.com/journals/lan...
May 15, 2024 at 23:12 UTC
6 replies
127 reposts
478 likes
Wow, great!
0 replies
0 reposts
0 likes
Oh, this is lovely news! Is there any prospect that this vaccine will lend itself to being a component of a “sterilizing vaccine”?
1 replies
0 reposts
4 likes
i hope if this works out and it becomes available that it'll be available globally
1 replies
0 reposts
5 likes
Well finally ☝️
0 replies
0 reposts
5 likes
Lets hope this pans out, might give us longer duration immunity.
0 replies
0 reposts
0 likes
Gimme
0 replies
0 reposts
7 likes